Vortioxetine eases depression in older adults, while cognitive gains stay mixed—showing selective boosts in attention and processing speed, not consistent global improvement.
|Articles|July 25, 2016
Positive Psychiaty, Resilience, and Aging
Author(s)Helen Lavretsky, MD, MS
The latest updates in geriatric psychiatry.
Advertisement
Dr Lavretsky discusses her thoughts on the state of geriatric psychiatry from the APA Annual Meeting. She is Professor of Psychiatry at UCLA. She also directs the Late Life Mood, Stress, and Wellness Research Program at the Semel Institute at UCLA. She is an editorial board member of Psychiatric Times.
Further reading:
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Defining Treatment-Resistant Depression In Adults
2
Interventional Options for TRD: ECT, TMS, and Esketamine
3
ARFID: When Remission Is Not Silence
4
Sexual Dysfunction in Depression: Assessing Pleasure Alongside Desire, Arousal, and Orgasm
5